Maxidim Injection 250 mg/vial contains Ceftazidime Pentahydrate, a third-generation cephalosporin antibiotic with potent activity against a wide range of Gram-negative and Gram-positive bacteria. It is especially effective against Pseudomonas aeruginosa and is commonly used in the treatment of serious and life-threatening infections. Maxidim Injection is intended for parenteral use and is administered under medical supervision in hospital or clinical settings.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Ceftazidime Pentahydrate equivalent to Ceftazidime 250 mg

• Dosage Form: Powder for injection

• Route of Administration: Intravenous or Intramuscular (after reconstitution)

Therapeutic Class

• Third-Generation Cephalosporin Antibiotic

Pharmacology

Ceftazidime is a bactericidal antibiotic that acts by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), leading to weakening of the bacterial cell wall and eventual cell lysis. Ceftazidime shows strong resistance to many beta-lactamases and demonstrates excellent activity against Gram-negative organisms, including Pseudomonas aeruginosa. After parenteral administration, it achieves therapeutic concentrations in various body tissues and fluids, including the lungs, urinary tract, skin, bone, and cerebrospinal fluid in inflamed meninges.

Indications

Maxidim Injection 250 mg/vial is indicated for the treatment of infections caused by susceptible organisms, including:

• Lower and upper respiratory tract infections

• Urinary tract infections

• Skin and soft tissue infections

• Bone and joint infections

• Intra-abdominal infections

• Septicemia

• Meningitis

• Infections in immunocompromised patients

It may also be used for empirical therapy in severe infections before the causative organism is identified.

Dosage and Administration

Dosage depends on the type and severity of infection, patient age, body weight, and renal function.

• Administered by intravenous or intramuscular injection after proper reconstitution

• Dose adjustments are required in patients with renal impairment

• Duration of therapy should be determined by the treating physician

Administration should be carried out by qualified healthcare professionals only.

Benefits and Key Features

• Broad-spectrum antibacterial activity

• Highly effective against Gram-negative pathogens, including Pseudomonas aeruginosa

• Suitable for severe and hospital-acquired infections

• Rapid bactericidal action

• Well-established clinical efficacy

Possible Side Effects

Like other cephalosporins, Maxidim Injection may cause side effects in some patients, including:

• Pain or inflammation at injection site

• Nausea or vomiting

• Diarrhea

• Skin rash or hypersensitivity reactions

• Transient changes in liver enzymes or blood counts

Most adverse effects are mild and reversible. Severe allergic reactions are rare but require immediate medical attention.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Contraindicated in patients with known hypersensitivity to cephalosporins

• Use with caution in patients with a history of penicillin allergy

• Monitor renal function during prolonged therapy

• Prolonged use may result in superinfection with non-susceptible organisms

• Use during pregnancy and lactation only if clearly indicated

Storage

• Store below 30°C in a dry place

• Protect from light

• Reconstituted solution should be used as per manufacturer’s instructions

• Keep out of reach of children

Conclusion

Maxidim Injection 250 mg/vial (Ceftazidime Pentahydrate) is a reliable and effective parenteral antibiotic for the treatment of serious bacterial infections. With its strong activity against resistant Gram-negative organisms and proven clinical performance, it plays a crucial role in modern antimicrobial therapy when used appropriately under medical supervision.